2023 | 東京大学大学院医学系研究科消化器内科

HOME
ABOUT US
2023

ORIGINAL ARTICLES

2023 No.1	Niikura R, Hayakawa Y, Nagata N, Miyoshi-Akiayama T, Miyabayashi K, Tsuboi M, Suzuki N, Hata M, Arai J, Kurokawa K, Abe S, Uekura C, Miyoshi K, Ihara S, Hirata Y, Yamada A, Fujiwara H, Ushiku T, Woods SL, Worthley DL, Hatakeyama M, Han YW, Wang TC, Kawai T, Fujishiro M. Non-Helicobacter pylori Gastric Microbiome Modulates Prooncogenic Responses and Is Associated With Gastric Cancer Risk Gastro Hep Advances. 2023 Feb 2(5): 684-700
2023 No.2	Endo G, Ishigaki K, Hamada T, Nakai Y, Ishida K, Kurihara K, Tange S, Takaoka S, Tokito Y, Suzuki Y, Oyama H, Kanai S, Suzuki T, Sato T, Hakuta R, Saito T, Takahara N, Fujishiro M. The impact of biliary stents on the diagnostic yield of endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions: A single-center retrospective study and meta-analysis. DEN Open. 2023 Jul 10;4(1):e250.
2023 No.3	Arai J, Niikura R, Hayakawa Y, Suzuki N, Honda T, Okamura T, Hasatani K, Yoshida N, Nishida T, Sumiyoshi T, Kiyotoki S, Ikeya T, Arai M, Boku N, Fujishiro M. Association of probiotic use with nivolumab effectiveness against various cancers: A multicenter retrospective cohort study. Cancer Med. 2023 Jul 8.
2023 No.4	Arai J, Niikura R, Yamada A, Aoki T, Suzuki N, Tsuji Y, Hayakawa Y, Kawai T, Fujishiro M. The Association between Diverticular Rebleeding and Early-Morning Blood Pressure and Surge: A Prospective Observational Trial. Digestion. 2023 Jul 5:1-9.
2023 No.5	Okushin K, Yamana H, Tateishi R, Sato M, Tsutsumi T, Matsui H, Fushimi K, Yasunaga H, Koike K, Fujishiro M. Treatment and outcome of hepatorenal syndrome in Japan: a retrospective cohort study using a national inpatient database. BMC Gastroenterol. 2023 Jun 23;23(1):218.
2023 No.6	Ishigaki K, Fukuda R, Nakai Y, Endo G, Kurihara K, Ishida K, Tange S, Takaoka S, Tokito Y, Suzuki Y, Oyama H, Kanai S, Suzuki T, Ito Y, Sato T, Hakuta R, Saito K, Saito T, Hamada T, Takahara N, Mizuno S, Kogure H, Fujishiro M. Retrospective comparative study of new slim-delivery and conventional large-cell stents for stent-in-stent methods for hilar malignant biliary obstruction. Dig Endosc. 2023 May 30.
2023 No.7	Arai J, Suzuki N, Hayakawa Y, Matzuzaki H, Yokoyama Y, Aoki T, Ishibashi R, Odawara N, Ihara S, Tsuji Y, Ishihara S, Fujishiro M. Severe obstructive colitis treated with repeated colonoscopic decompression. DEN Open. 2023 May 16;4(1):e233.
2023 No.8	Arai J, Niikura R, Hayakawa Y, Hirata Y, Ushiku T, Fujishiro M. Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis. Gut. 2023 May 17:gutjnl-2023-330052.
2023 No.9	Sakaguchi Y, Tsuji Y, Sato J, Kubota D, Obata M, Cho R, Nagao S, Miura Y, Ohki D, Mizutani H, Yakabi S, Kakushima N, Niimi K, Fujishiro M. Repeated steroid injection and polyglycolic acid shielding for prevention of refractory esophageal stricture. Surg Endosc. 2023 Aug;37(8):6267-6277.
2023 No.10	Arai J, Hayakawa Y, Niikura R, Ihara S, Aoki T, Honda T, Okamura T, Hasatani K, Yoshida N, Nishida T, Sumiyoshi T, Kiyotoki S, Ikeya T, Arai M, Fujishiro M. Letter: Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication a retrospective multicentre-cohort analysis. Aliment Pharmacol Ther. 2023 May;57(10):1196-1198.
2023 No.11	Mizutani S, Takahashi Y, Shimamoto T, Nakagawa H, Hisada H, Oshio K, Kubota D, Mizutani H, Ohki D, Sakaguchi Y, Yakabi S, Niimi K, Kakushima N, Tsuji Y, Wada R, Yamamichi N, Fujishiro M. Performing the ABC Method Twice for Gastric Cancer Risk Stratification: A Retrospective Study Based on Data from a Large-Scale Screening Facility. Diagnostics (Basel). 2023 Mar 28;13(7):1284.
2023 No.12	Nakada A, Niikura R, Otani K, Kurose Y, Hayashi Y, Kitamura K, Nakanishi H, Kawano S, Honda T, Hasatani K, Sumiyoshi T, Nishida T, Yamada A, Aoki T, Harada T, Kawai T, Fujishiro M. Improved Object Detection Artificial Intelligence Using the Revised RetinaNet Model for the Automatic Detection of Ulcerations, Vascular Lesions, and Tumors in Wireless Capsule Endoscopy. Biomedicines. 2023 Mar 17;11(3):942.
2023 No.13	Seimiya T, Otsuka M, Fujishiro M. Overcoming T-cell exhaustion: new therapeutic targets in HCC immunotherapy. Hepatology. 2023 Jan 3.
2023 No.14	Nakatsuka T, Tateishi R, Sato M, Fujishiro M, Koike K. Agile scores are a good predictor of liver-related events in patients with NAFLD. J Hepatol. 2023 Mar 3:S0168-8278(23)00161-7.
2023 No.15	Suzuki Y, Saito K, Nakai Y, Oyama H, Kanai S, Suzuki T, Sato T, Hakuta R, Ishigaki K, Saito T, Hamada T, Takahara N, Tateishi R, Fujishiro M. Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study. Support Care Cancer. 2023 Mar 2;31(3):197.
2023 No.16	Wake T, Tateishi R, Moriyama M, Fukumoto T, Yamada T, Nakagomi R, Nakatsuka T, Sato M, Minami T, Uchino K, Nakagawa H, Shiina S, Koike K, Fujishiro M. Steroid administration for ischemic complications after radiofrequency ablation: A retrospective study. Hepatol Res. 2023 Jul;53(7):675-680.
2023 No.17	Hamada T, Oyama H, Nakai Y, Tange S, Arita J, Hakuta R, Ijichi H, Ishigaki K, Kanai S, Kawaguchi Y, Kogure H, Mizuno S, Saito K, Saito T, Sato T, Suzuki T, Takahara N, Tanaka M, Tateishi K, Ushiku T, Hasegawa K, Fujishiro M. Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1792-1801.e3.
2023 No.18	Kado A, Inoue Y, Moriya K, Tsutsumi T, Ikeuchi K, Okushin K, Yotsuyanagi H, Koike K, Fujishiro M. Triglyceride level and soft drink consumption predict nonalcoholic fatty liver disease in nonobese male adolescents. Hepatol Res. 2023 Jun;53(6):497-510.
2023 No.19	Aoki T, Yamada A, Kobayashi K, Yamauchi A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Fujishiro M, Kaise M, Nagata N; Collaborators. Development and validation of a novel model for predicting stigmata of recent hemorrhage in acute lower gastrointestinal bleeding: Multicenter nationwide study. Dig Endosc. 2023 Feb 8.
2023 No.20	Arai J, Aoki T, Hayakawa Y, Niikura R, Suzuki N, Fujishiro M. Comments on "Epidemiology of overall and early-onset serrated polyps versus conventional adenomas in a colonoscopy screening cohort". Int J Cancer. 2023 Jun 1;152(11):2433-2435.
2023 No.21	Sato M, Akamatsu M, Shima T, Ikegami T, Yanase M, Mikami S, Imamura J, Nakatsuka T, Tateishi R, Yamauchi N, Ushiku T, Okanoue T, Fujishiro M, Hida E, Koike K. Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial. Am J Gastroenterol. 2023 Jan 20.
2023 No.22	Miura Y, Tsuji Y, Yoshio T, Hatta W, Yabuuchi Y, Hoteya S, Kikuchi D, Tsuji S, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Masamune A, Fujishiro M. Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study. Gastrointest Endosc. 2023 May;97(5):889-897.
2023 No.23	Sakaguchi Y, Saito Y, Ando M, Yoshida M, Fukuoka O, Kobayashi K, Kubota D, Ohki D, Mizutani H, Niimi K, Tsuji Y, Fujishiro M, Yamasoba T. Risk factors for incomplete resection with pharyngeal endoscopic submucosal dissection and long-term prognosis after resection. Endosc. 2023 May;37(5):3593-3601.
2023 No.24	Kurihara K, Takahara N, Hamada T, Kanai S, Hakuta R, Nakai Y, Fujishiro M. The "zipline" technique for endoscopic removal of a migrated pancreatic stent. Endoscopy. 2023 Dec;55(S 01):E299-E300.
2023 No.25	Kato H, Tateishi K, Iwadate D, Yamamoto K, Fujiwara H, Nakatsuka T, Kudo Y, Hayakawa Y, Ijichi H, Otsuka M, Kishikawa T, Takahashi R, Miyabayashi K, Nakai Y, Hirata Y, Toyoda A, Morishita S, Fujishiro M. HNF1B-driven three-dimensional chromatin structure for molecular classification in pancreatic cancers. Cancer Sci. 2023 Apr;114(4):1672-1685.
2023 No.26	Sato T, Saito T, Hamada T, Nakai Y, Fujishiro M. Rendezvous in WONderland: combined percutaneous and transluminal approach for an undrained area of massive walled-off necrosis. Endoscopy. 2023 Dec;55(S 01):E224-E225.
2023 No.27	Arai J, Aoki T, Hayakawa Y, Niikura R, Ishibashi R, Suzuki N, Tsuji Y, Yamada A, Ushiku T, Fujishiro M. Risk and preventive factors of early-onset colorectal neoplasms: endoscopic and histological database analysis. J Gastroenterol Hepatol. 2023 Feb;38(2):259-268.
2023 No.28	Sato T, Saito T, Hamada T, Nakai Y, Fujishiro M. A release from WONderland: endoscopic ultrasonography-guided reconnection of disconnected pancreatic ducts across a walled-off necrosis cavity. Endoscopy. 2023 Dec;55(S 01):E82-E83.
2023 No.29	Fukagawa K, Takahashi Y, Yamamichi N, Kageyama-Yahara N, Sakaguchi Y, Obata M, Cho R, Sakuma N, Nagao S, Miura Y, Tamura N, Ohki D, Mizutani H, Yakabi S, Minatsuki C, Niimi K, Tsuji Y, Yamamichi M, Shigi N, Tomida S, Abe H, Ushiku T, Koike K, Fujishiro M. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type. Gastric Cancer. 2023 Jan;26(1):44-54.
2023 No.30	Inokuma A, Takahara N, Ishibashi R, Hakuta R, Ishigaki K, Saito K, Saito T, Hamada T, Mizuno S, Yagioka H, Takahashi S, Kogure H, Sasaki T, Hirano K, Ito Y, Isayama H, Nakai Y, Koike K, Fujishiro M. Comparison of novel large-bore and conventional-bore covered self-expandable metal stents for malignant gastric outlet obstruction: Multicenter, retrospective study. Dig Endosc. 2023 Jan;35(1):111-121.